- Beam lays off 20% of staff and culls CAR-T work to save cash FierceBiotech
- Beam Therapeutics Announces Portfolio Prioritization and Strategic Restructuring Focused on Potential Near-term Value Drivers and Long-term Growth of Precision Genetic Medicines Pipeline GlobeNewswire
- Beam Therapeutics cuts 100 jobs The Boston Globe
- StockWatch: For Genome Editing, Inflection Points Crowd the Calendar Genetic Engineering & Biotechnology News
- Beam Therapeutics to lay off 20% of its staff, reevaluate programs as it cuts costs STAT
- View Full Coverage on Google News
Read original article here